| http://www.w3.org/ns/prov#value | - inion hotspots where treatment approaches differ between physicians and also between the US and Europe, such as the use of once daily oral dosing formulations for 5-ASAs- Assesses the impact of the 2011 SUCCESS trial- Identifies the most significant unmet needs, based on the treatment challenges facing physicians.
|
